Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL5153714 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Stearic Acid SCHEMBL867328 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Behenic Acid SCHEMBL5679682 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Decanoic Acid SCHEMBL5571660 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Nonanoate SCHEMBL5875028 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Palmitic Acid SCHEMBL5153293 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Octanoic Acid SCHEMBL5574283 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Heptanoate SCHEMBL5874922 | 1.00 | FABP3 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Tetrylammonium SCHEMBL5571730 | 0.98 | CA1 (0.62) | FABP3CA1CES2CES1BBOX1 | |
| Azelaic Acid SCHEMBL8778169 | 0.93 | BBOX1 (0.56) | FABP3CA1BBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858961-B2 | Solutions of quaternary and tertiary ammonium cation detergents to denature proteins, and kits for making them | AGILENT TECHNOLOGIES, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| CN-115448976-A | Use of quaternary ammonium cation and tertiary ammonium cation detergents in protein denaturation | 安捷伦科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-109714963-B | Use of quaternary ammonium cation and tertiary ammonium cation detergents in protein denaturation | 安捷伦科技有限公司 | 2022-08-09 | — | — | CN | disclosed |
| US-20210371454-A1 | Solutions of Quaternary and Tertiary Ammonium Cation Detergents to Denature Proteins, and Kits for Making Them | AGILENT TECHNOLOGIES, INC. (US) | 2021-12-02 | — | — | US | disclosed |
| US-11111268-B2 | Use of quaternary and tertiary ammonium cations to denature proteins | AGILENT TECHNOLOGIES, INC. (US) | 2021-09-07 | — | — | US | disclosed |
| EP-3500097-A1 | USE OF QUATERNARY AND TERTIARY AMMONIUM CATION DETERGENTS TO DENATURE PROTEINS | Prozyme, Inc. (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190169230-A1 | Use of Quaternary and Tertiary Ammonium Cations to Denature Proteins | PROZYME, INC. (US) | 2019-06-06 | — | — | US | disclosed |
| WO-2018035386-A1 | USE OF QUATERNARY AND TERTIARY AMMONIUM CATION DETERGENTS TO DENATURE PROTEINS | PROZYME, INC. (US) | 2018-02-22 | — | — | WO | disclosed |
| EP-1862329-A1 | Ink jet recording material and method of producing ink jet recording material | OJI PAPER CO., LTD. (JP) | 2007-12-05 | — | — | EP | disclosed |
| US-20070003716-A1 | Composite fine particles, dispersion, method of producing dispersion, ink jet recording material, and method of producing ink jet recording material | OJI PAPER CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| EP-1739136-A1 | Composite fine particles and ink jet recording material containing these particles. | OJI PAPER CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11111268-B2 | Use of quaternary and tertiary ammonium cations to denature proteins | PDIA3, STOM, PDIA6 | FABP3 383/4885CA1 320/4885CES2 2295/4885 |
| US-20190169230-A1 | Use of Quaternary and Tertiary Ammonium Cations to Denature Proteins | PDIA3, STOM, PDIA6 | FABP3 383/4885CA1 320/4885CES2 2295/4885 |
| US-11858961-B2 | Solutions of quaternary and tertiary ammonium cation detergents to denature proteins, and kits for making them | STOM, PDIA3, PDIA5 | FABP3 510/4885CA1 339/4885CES2 1882/4885 |
| US-20210371454-A1 | Solutions of Quaternary and Tertiary Ammonium Cation Detergents to Denature Proteins, and Kits for Making Them | STOM, PDIA3, PDIA5 | FABP3 510/4885CA1 339/4885CES2 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.